It isn't stamp collecting

Ebb & Flow

Among other proposed new offerings last week, Vanguard Medica in the U.K. is hoping to raise£30 million (US$45.9 million) in its first public flotation. Vanguard is developing drugs through in-licensing and collaborations, and is in Phase II trials with a migrane product licensed from SmithKline Beecham...